ReviewNutrients2026
The Chemopreventive and Anticancer Potential of Glucosinolates and Their Hydrolysis Products from Cruciferous Vegetables.
Review in Nutrients, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Dietary sulforaphane in cancer chemoprevention: epigenetic regulation and PRMT5-MEP50 complex inhibition-a systematic review.Frontiers in pharmacology · 2026Pooled it
- Design, Synthesis, and Biological Activity of Isothiocyanate-Triazine Conjugates as AChE and BACE1 Inhibitors.Biomolecules · 2026Article
- Isothiocyanates as Ferroptosis Inducers to Promote Cancer Cell Death.Phytotherapy research : PTR · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
objectivesGlucosinolates (GSLs) from cruciferous vegetables (CVs), sulfur (S)- and nitrogen-containing compounds, are enzymatically hydrolyzed by myrosinase (EC 3.2.1.147) to yield bioactive derivatives such as isothiocyanates (ITCs) and indoles. These metabolites exhibit chemopreventive and anticancer properties. The article compiles evidence regarding the following: (i) the molecular mechanisms regulating the biosynthesis of key derivatives, including sulforaphane (SFN), phenethyl isothiocyanate (PEITC), and indole-3-carbinol (I3C); (ii) epidemiological and clinical findings; and (iii) strategies to link plant science with nutritional interventions for cancer prevention.
methodsAn integrative literature review was conducted using Web of Science, Scopus, ScienceDirect, Google Scholar, and PubMed. English-language studies addressing mechanistic insights, nutritional factors, epidemiology, and clinical trials were included.
resultsThe biosynthesis and metabolism of GSL in plants are regulated by S and several transcription factors that promote or repress GSL production. Additionally, food processing has been shown to influence retention time and the formation of ITCs. In humans, ITCs activate nuclear factor erythroid 2-related factor 2 (Nrf2)-mediated detoxification, induce apoptosis, and modulate epigenetic pathways. Epidemiological data show inverse associations between CV intake and cancer risk, though variability exists. Clinical trials have confirmed the bioavailability and effects of glucoraphanin and SFN on cancer-related biomarkers.
conclusionsThe described compounds are bioavailable in humans and modulate the clinically relevant pathways linked to carcinogenesis. Larger, standardized interventions are needed to determine effective intake levels, optimize bioavailability, and define their potential role in evidence-based nutritional strategies for cancer prevention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.